Results 241 to 250 of about 476,670 (286)
JEADV Clinical Practice, EarlyView.ABSTRACT Background Lebrikizumab is approved to treat patients with moderate‐to‐severe atopic dermatitis (AD). Objectives This study evaluated the 16‐week efficacy outcomes of lebrikizumab in adults and adolescents with severe AD in ADvocate trials who would be eligible for treatment based on South Korean reimbursement‐like criteria. Methods This was a
Chong Hyun Won +11 more
wiley +1 more source
JEADV Clinical Practice, EarlyView.This systematic review and meta‐analysis aimed to examine the association between child atopic dermatitis and caregiver mental health. Fifteen observational studies were identified through PubMed, EMBASE, and Web of Science, excluding non‐English publications, clinical trials, and case reports.
Hannah Kang +6 more
wiley +1 more source
Land Degradation &Development, EarlyView.ABSTRACT Legislative frameworks that support gender equality are crucial for addressing structural inequalities, protecting women's rights, and achieving gender‐equitable land degradation neutrality (LDN) outcomes. This study examines the extent to which national‐level policies and legislation governing LDN and related sectors incorporate gender ...
Cynthia Nneka Olumba +1 more
wiley +1 more source
Med Research, EarlyView.Using data from the Global Burden of Disease Study 2021, we systematically assessed leukemia prevalence and disability‐adjusted life years (DALYs) across 204 countries and territories from 1990 to 2021, stratified by subtype, demographics, and risk factors.
Yuping Wu +8 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Brain and other central nervous system tumor statistics, 2021
Ca-A Cancer Journal for Clinicians, 2021Kimberly D Miller +2 more
exaly